AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 178 filers reported holding AXSOME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.98 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,177,077 | +10.5% | 531,937 | +13.7% | 0.11% | +8.0% |
| Q2 2023 | $33,630,696 | -53.4% | 468,003 | -60.0% | 0.10% | -55.2% |
| Q1 2023 | $72,154,929 | +43.9% | 1,169,827 | +80.0% | 0.22% | +31.2% |
| Q4 2022 | $50,139,513 | +81.9% | 650,065 | +5.2% | 0.17% | +54.5% |
| Q3 2022 | $27,571,000 | +1623.2% | 617,900 | +1379.1% | 0.11% | +1471.4% |
| Q2 2022 | $1,600,000 | -33.2% | 41,775 | -1.2% | 0.01% | -36.4% |
| Q1 2021 | $2,395,000 | -62.1% | 42,300 | -45.4% | 0.01% | -64.5% |
| Q4 2020 | $6,314,000 | -2.2% | 77,500 | -14.5% | 0.03% | -6.1% |
| Q3 2020 | $6,459,000 | -69.7% | 90,657 | -65.1% | 0.03% | -76.3% |
| Q2 2020 | $21,343,000 | -47.0% | 259,397 | -62.1% | 0.14% | -57.5% |
| Q1 2020 | $40,255,000 | +1143.2% | 684,254 | +327.7% | 0.33% | +1535.0% |
| Q3 2019 | $3,238,000 | +359.3% | 160,000 | -36.0% | 0.02% | +566.7% |
| Q4 2018 | $705,000 | – | 250,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |